A reminder to use product- or batch-specific information
Concerns about fertility: comparing the use of testosterone and hCG [3:00:30]
Gu Y, Li H, Bao X, Zhang Q, Liu L, Meng G, et al
Victoza is a once-daily GLP-1 RA therapy for patients with type 2 diabetes Indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes and to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease
It is often used in combination with other medications, like naltrexone, to increase its effectiveness for weight loss
For a broader primer on how research peptides are sourced, tested, and classified, see our complete peptide sciences research guide